排序方式: 共有5条查询结果,搜索用时 15 毫秒
1
1.
Zipora Tietel Sarit Melamed Noy Eretz-Kdosha Ami Guetta Raanan Gvirtz Navit Ogen-Shtern Arnon Dag Guy Cohen 《Molecules (Basel, Switzerland)》2021,26(19)
Jojoba (Simmondsia chinensis (Link) Schneider) wax is used for various dermatological and pharmaceutical applications. Several reports have previously shown beneficial properties of Jojoba wax and extracts, including antimicrobial activity. The current research aimed to elucidate the impact of Jojoba wax on skin residential bacterial (Staphylococcus aureus and Staphylococcus epidermidis), fungal (Malassezia furfur), and virus infection (herpes simplex 1; HSV-1). First, the capacity of four commercial wax preparations to attenuate their growth was evaluated. The results suggest that the growth of Staphylococcus aureus, Staphylococcus epidermidis, and Malassezia furfur was unaffected by Jojoba in pharmacologically relevant concentrations. However, the wax significantly attenuated HSV-1 plaque formation. Next, a complete dose–response analysis of four different Jojoba varieties (Benzioni, Shiloah, Hatzerim, and Sheva) revealed a similar anti-viral effect with high potency (EC50 of 0.96 ± 0.4 µg/mL) that blocked HSV-1 plaque formation. The antiviral activity of the wax was also confirmed by real-time PCR, as well as viral protein expression by immunohistochemical staining. Chemical characterization of the fatty acid and fatty alcohol composition was performed, showing high similarity between the wax of the investigated varieties. Lastly, our results demonstrate that the observed effects are independent of simmondsin, repeatedly associated with the medicinal impact of Jojoba wax, and that Jojoba wax presence is required to gain protection against HSV-1 infection. Collectively, our results support the use of Jojoba wax against HSV-1 skin infections. 相似文献
2.
David Nguyen Philippe-Henri Secrtan Camille Cotteret Emmanuelle Jacques-Gustave Cline Greco Christine Bodemer Joel Schlatter Salvatore Cisternino 《Molecules (Basel, Switzerland)》2022,27(3)
Recent studies have highlighted the benefit of repurposing oral erlotinib (ERL) treatment in some rare skin diseases such as Olmsted syndrome. The use of a topical ERL skin treatment instead of the currently available ERL tablets may be appealing to treat skin disorders while reducing adverse systemic effects and exposure. A method to prepare 0.2% ERL cream, without resorting to a pure active pharmaceutical ingredient, was developed and the formulation was optimized to improve ERL stability over time. Erlotinib extraction from tablets was incomplete with Transcutol, whereas dimethyl sulfoxide (DMSO) allowed 100% erlotinib recovery. During preliminary studies, ERL was shown to be sensitive to oxidation and acidic pH in solution and when added to selected creams (i.e., Excipial, Nourivan Antiox, Pentravan, and Versatile). The results also showed that use of DMSO (5% v/w), neutral pH, as well as a topical agent containing antioxidant substances (Nourivan Antiox) were key factors to maintain the initial erlotinib concentration. The proposed ERL cream formulation at neutral pH contains a homogeneous amount of ERL and is stable for at least 42 days at room temperature in Nourivan cream with antioxidant properties. 相似文献
3.
In the present cosmetic market, the skin image obtained from a hand-held camera is two-dimensional (2-D). Due to insufficient
penetration, only the skin surface can be detected, and thus phenomena in the dermis cannot be observed. To take the place
of the conventional 2D camera, a new hand-held imaging system is proposed for three-dimensional (3-D) skin imaging. Featuring
non-invasiveness, optical coherence tomography (OCT) has become one of the popular medical imaging techniques. The dermal
images shown in OCT-related reports were mainly single-colored because of the use of a monotonic light source. With three
original-colored beams applied in OCT, a full-colored image can be derived for dermatology. The penetration depth of the system
ranges from 0.43 to 0.78 mm, sufficient for imaging of main tissues in the dermis. Colorful and non-invasive perspectives
of deep dermal structure help to advance skin science, dermatology and cosmetology. 相似文献
4.
Simona Bungau Cosmin Mihai Vesa Areha Abid Tapan Behl Delia Mirela Tit Anamaria Lavinia Purza Bianca Pasca Laura Maghiar Todan Laura Endres 《Molecules (Basel, Switzerland)》2021,26(9)
Withaferin A (WFA) was identified as the most active phytocompound of the plant Withania somnifera (WS) and as having multiple therapeutic/ameliorating properties (anticancer, antiangiogenic, anti-invasive, anti-inflammatory, proapoptotic, etc.) in case of various diseases. In drug chemistry, WFA in silico approaches have identified favorite biological targets, stimulating and accelerating research to evaluate its pharmacological activity—numerous anticancer effects manifested in various organs (breast, pancreas, skin, colon, etc.), antivirals, anti-infective, etc., which are not yet sufficiently explored. This paper is a synthesis of the most relevant specialized papers in the field that are focused on the use of WFA in dermatological diseases, describing its mechanism of action while providing, at the same time, details about the results of its testing in in vitro/in vivo studies. 相似文献
5.
Miosz Lewandowski Zuzanna
wierczewska Wioletta Baraska-Rybak 《Molecules (Basel, Switzerland)》2022,27(10)
Botulinum toxin (BoNT) is a neurotoxin produced by the Clostridium botulinum bacteria. Among seven different isoforms, only BoNT-A and BoNT-B are commercially used. Currently, botulinum toxin has been indicated by the U.S. Food and Drug Administration in several disorders, among others: chronic migraine, hyperhidrosis, urinary incontinence from detrusor overactivity, or cosmetics. However, there are numerous promising reports based on off-label BTX usage, indicating its potential effectiveness in other diseases, which remains unknown to many. Among them, dermatological conditions, such as rosacea, annal fissure, Raynaud phenomenon, hypertrophic scars and keloids, and also hidradenitis suppurativa, are currently being investigated. This article aims to provide a comprehensive update on the off-label use of botulinum toxin in dermatology, based on an analysis and summary of the published literature. 相似文献
1